Navigation Links
FDA approves first drug for Huntington's disease
Date:8/15/2008

The U.S. Food and Drug Administration today approved tetrabenazine, the first drug approved for use in the United States to treat Huntington's disease, a fatal, inherited neurodegenerative disorder for which there is no cure. The action comes about eight months after an advisory panel unanimously voted to advise FDA to make the medication available to treat the disease.

The drug is already widely used in Europe, Canada and Australia to treat one of the most disabling symptoms of Huntington's disease, involuntary writhing movements known as chorea. Chorea is one of the trademark symptoms of the disease, which directly affects about 30,000 people in the United States today; another 70,000 people who are alive today will be diagnosed with the disease. FDA has classified tetrabenazine as an "orphan drug," since it's targeted to a disease that directly affects fewer than 200,000 people in the nation.

The pivotal study leading to the drug's approval was done by the Huntington Study Group, based at the University of Rochester Medical Center, and was led by Rochester neurologist Frederick J. Marshall, M.D. That study, published in the journal Neurology in 2006, found that the medication cut down involuntary movements on average by about 25 percent, with many patients experiencing a greater improvement. Overall, patients who received the medication were six times as likely to be considered by their doctors to have improved considerably, compared to participants who received a placebo.

"This is a huge deal," said Marshall. "Ninety percent of patients with Huntington's disease have chorea, and many suffer terribly. It's hard to describe the torment that these people undergo. We had several patients who experienced a dramatic improvement in their quality of life. Some patients who hadn't been able to attend church for years were able to do so. Others were able to go out to a restaurant and have a meal for the first time in years. It's impossible
'/>"/>

Contact: Tom Rickey
tom_rickey@urmc.rochester.edu
585-275-7954
University of Rochester Medical Center
Source:Eurekalert

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. The California Board of Registered Nursing Approves Affiliations for Nursing Program in Glendale, California
2. Kaiser Permanente Approves $22 Million in Community Benefit Grants in Second Quarter of 2008
3. Hillenbrand, Inc. Board of Directors Approves $100M Share Repurchase Program
4. Edwards Lifesciences Board Approves New $250 Million Share Repurchase Program
5. Congress Approves ePrescribing Initiative in Medicare Reform Bill: Critical Catalyst in Driving a New Generation of Prescribing
6. FDA Approves Genetic Test for Breast Cancer
7. FDA Approves KINRIX(TM) - New Combination Vaccine for Children
8. FDA Approves VELCADE(R) (Bortezomib) for Injection for Patients with Previously Untreated Multiple Myeloma
9. Japan Approves CyberKnife System for Extracranial Use
10. FDA approves NeuRx diaphragm pacing system for use in spinal cord- injured patients
11. FDA Approves Cymbalta(R) for the Management of Fibromyalgia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2013)... May 24, 2013 The creative flair ... Kong Polytechnic University (PolyU)'s Institute of Textiles and Clothing ... annual Knitwear Fashion Show held on 22 May at ... concerted effort of ITC design students, various knitwear producers ... showcased 20 collections of four outfits from 20 graduating ...
(Date:5/24/2013)... Salt Lake City, UT (PRWEB) May 24, 2013 ... of MonaVie Latin America, as a new member of the ... , “I am proud to have been elected to this ... the ethical basis of the direct selling industry,” says Patrocinio. ... is a positive contributor to Brazil’s economy. The direct selling ...
(Date:5/24/2013)... PA (PRWEB) May 24, 2013 Patients ... be more likely to suffer from gastroesophageal reflux disease ... physicians reported in a study published today. , The ... Abnormal Proximal Exposure as Measured by Hypopharyngeal Multichannel Intraluminal ... findings could be of great importance to individuals who ...
(Date:5/24/2013)... 24, 2013 Chronic Fatigue Syndrome has ... sufferers with unexplained fatigue lasting 6 months or longer. ... memory and concentration impairment, muscle and joint pain without ... un-refreshing sleep and malaise that lasts for more than ... known to be linked to insulin resistance. At a ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 DiaperBuys.com is ... Baby Photo Contest. Lindsey Willis of Olathe, Kansas, won ... from DiaperBuys. Second prize was a three-month supply ... North Las Vegas, Nev.; and third prize, a one-month ... The contest was run through the company’s Facebook page. ...
Breaking Medicine News(10 mins):Health News:PolyU Stages Knitwear Fashion Show 2Health News:MonaVie Brazil Executive Elected to Ethics Board of ABEVD 2Health News:West Penn Allegheny Health System Physicians Pinpoint Gastroesophageal Reflux Disease (GERD) as a Factor That May Cause Chronic Cough 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans to Promote Fast Weight Loss Shown to Reduce the Risk & Symptoms of Chronic Fatigue 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces New hCG Diet Plans to Promote Fast Weight Loss Shown to Reduce the Risk & Symptoms of Chronic Fatigue 3Health News:DiaperBuys.com Announces Photo Contest Winners 2
... ... begun the new year by expanding their existing Green Bay, WI presence with the ... ... growing technology company representing both businesses and residents has joined forces with Buildmyownsite, Inc., ...
... ... them on a road to schizophrenia may be protected against some forms of cancer, according to ... ... inherit a specific form of a gene that puts them on a road to schizophrenia may ...
... emergency department, federal report shows , THURSDAY, Jan. 14 ... million motor vehicle crash victims who had injuries ranging ... a new government study finds. , About 85 percent ... 321,000 were admitted or transferred to another acute care ...
... but doing it takes reporter from the brink of ... to roll your eyes when a doctor prescribes diet and exercise as ... for me. , In the past year, I used diet and ... my cholesterol. I did it armed with knowledge given to me by ...
... , WASHINGTON , Jan. 15 ... small amount of cognitive training can cut the crash risk of older drivers ... meeting of the Transportation Research Board of the National Academy of Sciences. ... join the ranks of some 39 million drivers already over age 65. Over ...
... ... concern of hospitals is keeping their patients safe while within their facility. To ... identifiers to patients that may present a higher risk of falling while in ... for a variety of reasons, have a higher than normal risk of being ...
Cached Medicine News:Health News:Infinity Technology, Inc. Acquires Build My Own Site, Inc. 2Health News:Gene Linked to Schizophrenia May Reduce Cancer Risk 2Health News:From Risky Health Status to a Better Life 2Health News:From Risky Health Status to a Better Life 3Health News:From Risky Health Status to a Better Life 4Health News:From Risky Health Status to a Better Life 5Health News:Brain Fitness Predicts Crash Risk 2Health News:Brain Fitness Predicts Crash Risk 3Health News:Brain Fitness Predicts Crash Risk 4Health News:Midbrook Assists Local Hospital with Fall Kit Production 2Health News:Midbrook Assists Local Hospital with Fall Kit Production 3
(Date:5/23/2013)... 2013 3SBio Inc. (NASDAQ: ... China -based biotechnology company focused ... announced today that, at an extraordinary general meeting ... in favor of the proposal to authorize and ... merger dated February 8, 2013, among Decade Sunshine ...
(Date:5/23/2013)... SAN DIEGO , May 23, 2013 Neurocrine ... Kevin Gorman , President and Chief Executive ... Bank 38 th Annual dbAccess Health Care Conference in ... Thursday, May 30 at 11:20 a.m. Eastern Time / 8:20 ... be accessed on the Company,s website at http://www.neurocrine.com . ...
(Date:5/23/2013)... May 23, 2013 Nephros, Inc. (OTC Bulletin ... device company that develops and sells high performance liquid ... rights offering.  In addition, the concurrent temporary reduction in ... on May 17, 2013. Nephros estimates that ... the rights offering.   A portion of the proceeds will ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... Amgen (Nasdaq: AMGN ) will participate in the ... St. Regis New York in New York City, beginning at ... of Global Development, for Amgen, will present at the conference. ... Internet and can be accessed from Amgen,s website, www.amgen.com ...
... Transgenomic, Inc. (OTC Bulletin Board: ... for CE IVD labeling and has significantly expanded distribution ... most of the European Union. The SURVEYOR Scan K-RAS ... of mutation detection kits, which features proprietary SURVEYOR endonuclease ...
Cached Medicine Technology:Transgenomic Expands Distribution of SURVEYOR® Scan K-RAS Mutation Detection Kit With CE IVD Mark 2Transgenomic Expands Distribution of SURVEYOR® Scan K-RAS Mutation Detection Kit With CE IVD Mark 3Transgenomic Expands Distribution of SURVEYOR® Scan K-RAS Mutation Detection Kit With CE IVD Mark 4Transgenomic Expands Distribution of SURVEYOR® Scan K-RAS Mutation Detection Kit With CE IVD Mark 5
Extremely fine straight....
Micro-Scissors "micro 2000". 12 mm, straight, extra-wide serrated handles....
Micro 2000 suture forceps light-weight instruments with blue-colored anodized round handles, extremely light weight, well balanced, easy to handle, fatigueless working, easy to maintain, corrosion-re...
Round tip, sharp all around, angled....
Medicine Products: